Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/Akt/ERK and IGF-1R pathways independent of ERα

Lam, L., Hu, X., Aktary, Z., Andrews, D.W., and Pasdar, M., Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/Akt/ERK and IGF-1R pathways independent of ERα. (2008) Breast Cancer Research and Treatment, 118(3):605-21, DOI: 10.1007/s10549-008-0231-y.